Why Precision Alone Isn't Enough in Oncology Drug Discovery
Precision alone isn’t enough in oncology drug discovery. See why execution, biomarkers, and trial design determine scalable success in precision medicine.
Insights
In-depth articles and expert analysis from pharmaceutical leaders, exploring advances in life sciences, drug development and the trends shaping healthcare innovation.
Image
The Future for Decentralised Clinical Trials
Image
Reimagine AI-driven Drug Discovery with Pharmaceutical Superintelligence
Image
First Quarter 2026 State of Digital Health Funding
Image
Maximise Pharma Innovation With Quality-by-Design
Image
Digital Twins in Clinical Trials: Simulating Success Before Enrolment
Image
Phenotypic Drug Discovery: Beyond the Target
Image
The Looming Threat of Geopolitical Risk in Clinical Supply Chains
Explore All Insights
Browse our complete library of expert articles and analysis. Explore content across science, policy and life sciences innovation.
Modern Drug Discovery Challenges Demand a New Pharma Paradigm
Explore the biggest drug discovery challenges facing pharma today, from translational gaps to AI integration, and why a new pharma paradigm is needed.
Preclinical vs Clinical Research Strategy for Drug Development
Explore the critical differences between preclinical vs clinical research, and how closing the translation gap can reduce drug development attrition and improve R&D decision-making.
Close the Drug Discovery Loop by Leveraging the DMTA Cycle
The DMTA cycle is the engine of modern pharma R&D. Learn how integrated DMTA workflows reduce early-stage attrition and compress drug discovery timelines.